North America Stem Cell Market Share

Statistics for the 2023 & 2024 North America Stem Cell market share, created by Mordor Intelligence™ Industry Reports. North America Stem Cell share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Stem Cell Industry

The North American stem cell market, which is highly competitive, consists of several major players. These companies focus on expanding their offerings through extensive R&D and forming alliances and partnerships with other major players to sustain their market position. Becton, Dickinson and Company, Lineage Cell Therapeutics, Inc., Brainstorm Cell Therapeutics, International Stem Cell Corp., Miltenyi Biotec, Osiris Therapeutics Inc., Merck KGaA (Sigma Aldrich) Stem Cell Technologies, Bristol-Myers Squibb Company, and Thermo Fisher Scientific

North America Stem Cell Market Leaders

  1. Becton, Dickinson and Company

  2. Thermo Fisher Scientific

  3. Lineage Cell Therapeutics, Inc.,

  4. Merck KGaA (Sigma Aldrich)

  5. Bristol-Myers Squibb Company

*Disclaimer: Major Players sorted in no particular order

Picture1.png

North America Stem Cell Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)